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Abstract 
Objective: Repeat expansion of polyglutamine tracks leads to a group of inherited human neurodegenerative 
disorders. Studying such repetitive sequences is required to gain insight into the pathophysiology of these diseases. 
PCR-based manipulation of repetitive sequences, however, is challenging due to the absence of unique primer bind-
ing sites or the generation of non-specific products.
Results: We have utilised the degeneracy of the genetic code to generate a polyglutamine sequence with low 
repeat similarity. This strategy allowed us to use conventional PCR to generate multiple constructs with approximately 
defined numbers of glutamine repeats. We then used these constructs to measure the in vivo variation in autophagic 
degradation activity related to the different numbers of glutamine repeats, providing an example of their applicabil-
ity to study repeat expansion diseases. Our simple and easily generalised method of generating low repetition DNA 
sequences coding for uniform stretches of amino acid residues provides a strategy for generating particular lengths of 
polyglutamine tracts using standard PCR and cloning protocols.
Keywords: Polyglutamine repeats, Codon redundancy, Degeneracy of the genetic code, PCR based repeat region 
amplification, Aggregate proteins, Autophagy
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Introduction
The aberrant expansion of unstable CAG repeats cod-
ing for polyglutamine (polyQ) tracts underlies a group 
of neurodegenerative diseases, including Huntington’s 
disease (HD) and several forms of spino-cerebellar 
ataxia (SCA) [1]. These diseases exhibit polyQ length-
dependent toxicity, whereby age at disease onset is 
inversely correlated to the number of polyQ repeats [2]. 
They display common cellular and molecular mecha-
nisms including protein aggregation and inclusion 
body formation [3]. Such protein aggregates depend 
strongly on autophagy for their clearance and dysfunc-
tion of this pathway may contribute to the pathology of 
these diseases [4]. Enhancement of autophagy has been 
suggested to have possible therapeutic value in such 
diseases showing protein aggregation by promoting 
the clearance of these aggregates and protecting cells 
against their toxic effects [5, 6]. However, studying the 
influence of polyQ tract length on aggregation kinet-
ics is challenging due to difficulties faced when cloning 
repetitive DNA sequences primarily due to the lack of 
unique primer binding sites [7, 8]. Previously, several 
polymerase chain reaction (PCR) based methods to 
amplify repetitive DNA regions have been described 
[9–11]. However, most of these either generate nonspe-
cific products, flawed repeats, or a collection of clones 
with varying numbers of repeats making the identifica-
tion and isolation of the specific clone of interest labo-
rious [12–14]. In order to investigate the autophagic 
degradation activity or ‘autophagic flux’ of polyQ pro-
tein aggregates we sought to clone reporter constructs 
containing more closely defined numbers of glutamine 
residues. We designed a polyQ sequence with low 
repeat similarity by exploiting the codon redundancy 
of the genetic code. This strategy allowed us to amplify 
close to the desired numbers of glutamine repeats 
(although still with some variability due to two distinct 
causes), which we subsequently used to assess in  vivo 
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variations in ‘autophagic flux’ in a larval zebrafish model 
for Alzheimer’s disease [15].
Main text
Results and discussion
The ‘autophagic flux’ assay described in Jiang et  al. [15] 
is a quantitative green fluorescent protein (GFP) reporter 
assay that measures the ratiometric changes of polyQ-
GFP to free GFP via Western blot analysis. A multicis-
tronic reporter construct was designed to code for two 
proteins; polyQ linked to N-terminal GFP and free GFP. 
The viral 2A (v2A) sequence was placed as a linker region 
between the sequences coding for the two proteins to 
enable stoichiometric translation of two separate pro-
teins from one open reading frame (Fig. 1a) [16].
We designed a polyQ sequence containing 80 glu-
tamine repeats  (Q80). The sequence was designed to 
have low repeat similarity by randomly interspacing glu-
tamine-coding CAG triplets with glutamine-coding CAA 
triplets (Fig.  1b, c). The nucleotide substitutions were 
made by eye to generate a semi random pattern. This 
non-repetitive sequence design should not only enhance 
sequence stability during propagation in bacteria but also 
enabled the design of PCR primers that annealed to spe-
cific regions of the sequence.
The  Q80-GFP-v2A-GFP construct described above was 
commercially synthesised (Biomatik Corporation) (see 
Additional file  1) and sub-cloned via the BamHI and 
ClaI restriction sites into the Tol2 transposon-based, 
pT2AL200R150G gene transfer vector (hereafter referred 
to as Tol2) available from the Kawakami laboratory [17] 
(Fig. 1a and see Additional file 2).
PolyQ constructs with lower numbers of glutamine 
repeats were generated by PCR-based exclusion ampli-
fication of the Tol2-Q80-GFP-v2A-GFP construct. The 
primers were designed to amplify around the vector 
excluding a defined number of glutamine repeats to gen-
erate the constructs of interest (Fig. 1d–f). We aimed to 
generate vectors with approximately 52  (Q52), 31  (Q31) 
and 10  (Q10) glutamine repeats. The putative  Q52 and  Q31 
vectors were generated using the same reverse primer 
coupled with different forward primers. This common 
reverse primer amplified 2 glutamine repeats, while 
the forward primers amplified the additional 50 and 29 
glutamine repeats needed to generate the  Q52 and  Q31 
vectors, respectively. The position of the reverse primer 
was shifted slightly to optimise the amplification of the 
putative  Q10 vector, such that the reverse primer now 
amplified 5 glutamine repeats while the forward primer 
amplified the remaining 5 glutamine repeats (Fig.  1d–
f). By using stringent annealing temperatures in the 
PCR reaction we obtained specific primer binding. Gel 
extracted and purified PCR products were phosphoryl-
ated, circularised by self-ligation and subsequently trans-
formed into competent cells (see Additional file 3). PCR 
using primers that flanked the polyQ region showed 
approximately expected product sizes for the intended 
putative  Q52,  Q31 and  Q10 vectors (Fig.  1g). The gener-
ated constructs were sequenced to determine whether 
the expected polyQ repeat numbers were present. While 
the  Q52 construct had the expected number of glutamine 
repeats (Fig.  2a, b), sequencing revealed minor discrep-
ancies with expected polyQ numbers for the other two 
constructs, where the Tol2-Q31-GFP-v2A-GFP vector 
had 21-glutamine repeats (hereafter referred to as Tol2-
Q21-GFP-v2A-GFP) (Fig.  2c, d) and the Tol2-Q10-GFP-
v2A-GFP vector had 11-glutamine repeats (hereafter 
referred to as Tol2-Q11-GFP-v2A-GFP) (Fig.  2e, f ). Fur-
ther analysis revealed that the generated  Q21 sequence 
was derived directly from the original sequence and the 
loss of glutamine repeats was due to the  Q31 forward 
primer binding 30  bp downstream from the predicted 
binding site. In contrast, the additional glutamine repeat 
in the  Q11 sequence was generated de novo, an addition 
of a CAA codon.
To study the aggregation kinetics and ‘autophagic flux’ 
of polyQ protein in  vivo, we injected the generated polyQ 
vectors (25 ng/μL) and transposase mRNA (25 ng/μL) into 
groups of one-cell-stage zebrafish embryos (Fig.  3a, b). 
Western blot analysis with anti-GFP antibody of 24 h post 
fertilisation (hpf) embryo lysates (10 embryos per sam-
ple) was carried out for each group. The empty Tol2 vector 
(25 ng/μL) and transposase mRNA (25 ng/μL) injected and 
un-injected embryos were included as controls. Embryos 
injected with the polyQ constructs produced two bands 
detected by the anti-GFP antibody as expected; GFP 
attached to polyQ  (polyQ80-GFP at ~ 48 kDa,  polyQ52-GFP 
at ~ 38  kDa,  polyQ21-GFP at ~ 33  kDa and  polyQ11-GFP 
Fig. 1 Generating the putative  Q52,  Q31 and  Q10-GFP constructs using the Tol2-Q80-GFP-v2A-GFP multicistronic reporter construct. a Vector map 
of the Tol2-Q80-GFP-v2A-GFP construct. b Summary of CAA and CAG degenerate codon usage in this construct. c Chromatograph of the construct 
depicting the randomly interspaced glutamine coding CAG and CAA triplets. d Schematic illustration of PCR-based exclusion amplification of the 
 Q80-GFP containing construct to generate polyQ constructs with lower numbers of glutamine repeats. e  Q80 sequence showing  Q52,  Q31 and  Q10 
primer binding sites. f Sequences of primers intended to generate  Q52,  Q31 and  Q10 constructs. g Analytical agarose gel electrophoresis for each 
of the putative  Q80,  Q52,  Q31 and  Q10 vectors using primers flanking the polyQ region. PCR product sizes of ~ 270, ~ 180, ~ 120 and ~ 60 bp for the 
intended putative  Q80,  Q52,  Q31 and  Q10-GFP constructs, respectively, were seen
(See figure on next page.)
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at ~ 31  kDa), and free GFP (~ 27  kDa) (Fig.  3c). Each of 
the polyQ-GFP construct expressing embryo lysates also 
showed a fainter band of higher protein size correspond-
ing to the full length  polyQX-GFP-v2A-GFP construct 
 (polyQ80-GFP-v2A-GFP at ~ 75 kDa,  polyQ52-GFP-v2A-GFP 
at ~ 65  kDa,  polyQ21-GFP-v2A-GFP at ~ 60  kDa, and 
 polyQ11-GFP-v2A-GFP at ~ 58  kDa). This band represents 
the ~ 10% of the total protein that is translated as a single, 
full-length protein when using the v2A sequence system 
[18]. The  Q80-GFP:GFP,  Q52-GFP:GFP,  Q21-GFP:GFP and 
 Q11-GFP:GFP ratios are ~ 5, ~ 4, ~ 2 and ~ 1, respectively 
(Fig. 3d). As the v2A sequence allows for the stoichiometric 
translation of the polyQ-GFP and GFP proteins, in theory 
the polyQ-GFP:GFP ratio should be 1. The greater ratios 
observed may indicate an accumulation of those proteins. 
These observations are in agreement with the literature, 
where it has been shown that polyQ-GFP fusion constructs 
containing greater than 19 glutamine residues aggre-
gate within transfected cells in a length-dependent man-




Fig. 2 Vector map and sequence analysis of the constructs coding for  Q52,  Q21 and  Q11-GFP generated by PCR based excision amplification. 
a Vector map of Tol2-Q52-GFP-v2A-GFP construct. b Chromatograph of the  Q52 construct. c Vector map of Tol2-Q21-GFP-v2A-GFP construct. d 
Chromatograph of the  Q21 construct. e Vector map of Tol2-Q11-GFP-v2A-GFP construct. f Chromatograph of the  Q11 construct
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Tol2-QX-GFP-v2A-GFP constructs provide a useful tool to 
study ‘autophagic flux’ in vivo in a larval zebrafish model.
Conclusion
In conclusion this study provides a robust and easily 
adoptable solution to generate close to intended lengths 
of polyQ repeats. In order to generate exact numbers of 
glutamine repeats subsequent rounds of amplifications 
with altered primer sequences can be carried out. In 
addition the primer length can be increased to enhance 
specificity of primer annealing to the template. Our tech-
nique has several advantages over the existing methods 























































Fig. 3 Analysis of the Tol2-QX-GFP-v2A-GFP construct expression in D. rerio. Zebrafish embryos were injected with 25 ng/µL of the 
Tol2-QX-GFP-v2A-GFP construct and 25 ng/µL mRNA coding for Tol2 transposase. a Brightfield (top panels) and fluorescent (bottom panels) images 
of the left side view of zebrafish embryo head and trunk regions expressing  Q80,  Q52,  Q21 and  Q11-GFP, ~ 24 hpf. b Brightfield (top panels) and 
fluorescent (bottom panels) images of the left side view of zebrafish embryo trunk and tail regions expressing  Q80,  Q52,  Q21 and  Q11-GFP, ~ 24 hpf. 
c Western blot analysis of the expression of  Qx-GFP constructs in D. rerio. Proteins were isolated from ~ 24 hpf embryos expressing the  Q80,  Q52,  Q21 
and  Q11-GFP constructs. The proteins were resolved on a 10% SDS-PAGE gel and transferred to a nitrocellulose membrane. The membrane was 
probed with an anti-GFP antibody. The “empty” Tol2 vector possesses an expressed GFP gene that is replaced during construct insertion. d Western 
blot quantification. The GFP intensity for each numbered band of the Western blot and the  Qx-GFP to free GFP ratio are presented
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for PCR-based amplification of repetitive regions and 
aims to minimise the generation of non-specific PCR 
products and flawed repeats by exploiting the codon 
redundancy of the genetic code to generate a synony-
mous DNA coding sequence with reduced repetition. 
In addition, our approach is not limited to generating 
polyQ repeat sequences but can also be generalised to 
generate other nucleotide repeat sequences. Further-
more, our method is relatively cheap, as only the initial 
 polyQ80-GFP-v2A-GFP construct requires commercial 
synthesis, the cost of which depends on the price per 
nucleotide base, length, purity and mass. All other mate-
rials required are standard reagents used for molecular 
cloning. In summary the technique described provides an 
easy to adopt, affordable solution to generate repeat-cod-
ing DNA sequences that can be manipulated as required.
Limitations
  • Initial construct requires commercial synthesis.




Q80: 80 glutamine repeats; GFP: green fluorescent protein; hpf: hours post 
fertilisation; HD: Huntington’s disease; polyQ: polyglutamine; PCR: polymerase 
chain reaction; SCA: spino-cerebellar ataxia; v2A: viral 2A.
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